Stefania Bellone

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

Amanda N. Fader, Dana M. Roque, Eric R. Siegel et al. · Journal of Clinical Oncology · 2018 · 509 citations · Full text

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer

Mingzhu Yin, Xia Li, Shu Tan et al. · Journal of Clinical Investigation · 2016 · 426 citations · Full text

Tumor-associated Macrophages, Mammary Gland Development, Medicine +15

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

Siming Zhao, Murim Choi, John D. Overton et al. · Proceedings of the National Academy of Sciences · 2013 · 333 citations · Full text

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy

Alessandro D. Santin, Fenghuang Zhan, Stefania Bellone et al. · International Journal of Cancer · 2004 · 323 citations · Full text

Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Amanda N. Fader, Dana M. Roque, Eric R. Siegel et al. · Clinical Cancer Research · 2020 · 292 citations · Full text